IDEXX Laboratories, Inc.
IDXX Healthcare Diagnostics & Research
IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.66%, EPS grew 17.2%, free cash flow grew 111.4% and total debt fell 14.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three.
Follow IDXX
IDEXX Laboratories, Inc. (IDXX) EV/FCF
As of 16 October 2026, IDEXX Laboratories, Inc. (IDXX) trades at a EV/FCF of 36.0×. Over the past ten years it has ranged from 32.4× (September 2026) to 114× (February 2023); the current reading is higher than 2% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 57.2× | 19.74% |
| FY2024 | 47.7× | (20.37%) |
| FY2023 | 60.0× | (33.45%) |
| FY2022 | 90.1× | 0.16% |
| FY2021 | 89.9× | 12.56% |
| FY2020 | 79.9× | 1.34% |
| FY2019 | 78.9× | 30.26% |
| FY2018 | 60.5× | 28.37% |
| FY2017 | 47.2× | 20.22% |
| FY2016 | 39.2× | (22.36%) |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 33.8× | (20.52%) |
| Mar 2026 | 42.5× | (25.60%) |
| Dec 2025 | 57.2× | (4.17%) |
| Sep 2025 | 59.6× | (4.36%) |
| 42 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| DGX Quest Diagnostics Incorporated compare | 23.1× |
| IQV IQVIA Holdings Inc. compare | 25.8× |
| LH Labcorp Holdings Inc. compare | 30.8× |
| IDXX IDEXX Laboratories, Inc. | 36.0× |
| A Agilent Technologies, Inc. compare | 39.9× |
| MTD Mettler-Toledo International, Inc. compare | 40.2× |
| ILMN Illumina, Inc. compare | 44.1× |
| WAT Waters Corporation compare | 129× |
| NTRA Natera, Inc. compare | 658× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on IDXX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement